Memorandum of Understanding by and Between the United States Food and Drug Administration and the International Anesthesia Research Society for the Safety of Key Inhaled and Intravenous Drugs in Pediatrics Public-Private Partnership, 31450-31457 [2010-13292]
Download as PDF
<![CDATA[
31450
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
and discussed at this meeting. These
discussions are likely to reveal personal
information concerning individuals
associated with the applications. This
information is exempt from mandatory
disclosure under the above-cited
statutes.
SEP Meeting on: AHRQ Limited
Competition: PROSPECT STUDIES—
Building New Clinical Infrastructure for
CE (R01).
Date: June 16, 2010 (Open on June 16
from 8 a.m. to 8:15 a.m. and closed for
the remainder of the meeting).
Place: Hyatt Regency Bethesda Hotel,
7400 Wisconsin Avenue, 1 Bethesda
Metro Center, Bethesda, Maryland
20814.
Contact Person: Anyone wishing to
obtain a roster of members, agenda or
minutes of the non-confidential portions
of this meeting should contact Mrs.
Bonnie Campbell, Committee
Management Officer, Office of
Extramural Research, Education and
Priority Populations, AHRQ, 540
Gaither Road, Room 2038, Rockville,
Maryland 20850, Telephone (301) 427–
1554.
Agenda items for this meeting are
subject to change as priorities dictate.
Dated: May 24, 2010.
Carol M. Clancy,
Director.
[FR Doc. 2010–13109 Filed 6–2–10; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality; Notice of Meeting
sroberts on DSKD5P82C1PROD with NOTICES
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
conduct on an as-needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for the OS ARRA:
Optimizing Prevention and Healthcare
Management for Complex Patients (R21)
applications are to be reviewed and
discussed at this meeting. These
discussions are likely to reveal personal
information concerning individuals
associated with the applications. This
information is exempt from mandatory
disclosure under the above-cited
statutes.
SEP Meeting on: OS ARRA:
Optimizing Prevention and Healthcare
Management for Complex Patients
(R21).
Date: June 24, 2010 (Open on June 24
from 8 a.m. to 8:15 a.m. and closed for
the remainder of the meeting).
Place: Hilton Rockville Executive
Meeting Center, 1750 Rockville Pike,
Conference Room TBD, Rockville, MD
20850.
Contact Person: Anyone wishing to
obtain a roster of members, agenda or
minutes of the nonconfidential portions
of this meeting should contact Mrs.
Bonnie Campbell, Committee
Management Officer, Office of
Extramural Research, Education and
Priority Populations, AHRQ, 540
Gaither Road, Room 2038, Rockville,
Maryland 20850, Telephone (301) 427–
1554.
Agenda items for this meeting are
subject to change as priorities dictate.
Dated: May 24, 2010.
Carolyn M. Clancy,
Director.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0004]
[FDA 225–09–0014]
Memorandum of Understanding by and
Between the United States Food and
Drug Administration and the
International Anesthesia Research
Society for the Safety of Key Inhaled
and Intravenous Drugs in Pediatrics
Public-Private Partnership
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is providing
notice of a memorandum of
understanding (MOU) between FDA and
the International Anesthesia Research
Society (IARS). The purpose of this
MOU is to establish a framework for
collaboration between FDA and IARS
and to support their shared interest of
promoting the safe use of anesthetics
and sedatives in children.
DATES: The agreement became effective
March 21, 2010.
FOR FURTHER INFORMATION CONTACT:
Wendy R. Sanhai, Senior Scientific
Advisor, Office of the Commissioner,
Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 32, rm.
4128, Silver Spring, MD 20993, 301–
796–8518.
In
accordance with 21 CFR 20.108(c),
which states that all written agreements
and MOUs between FDA and others
shall be published in the Federal
Register, the agency is publishing notice
of this MOU.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2010–13108 Filed 6–2–10; 8:45 am]
Dated: May 26, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
BILLING CODE 4160–90–M
BILLING CODE 4160–01–S
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
E:\FR\FM\03JNN1.SGM
03JNN1
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4725
E:\FR\FM\03JNN1.SGM
03JNN1
31451
EN03JN10.008</GPH>
sroberts on DSKD5P82C1PROD with NOTICES
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
VerDate Mar<15>2010
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
18:21 Jun 02, 2010
Jkt 220001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4725
E:\FR\FM\03JNN1.SGM
03JNN1
EN03JN10.009</GPH>
sroberts on DSKD5P82C1PROD with NOTICES
31452
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
PO 00000
Frm 00042
Fmt 4703
Sfmt 4725
E:\FR\FM\03JNN1.SGM
03JNN1
31453
EN03JN10.010</GPH>
sroberts on DSKD5P82C1PROD with NOTICES
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
VerDate Mar<15>2010
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
18:21 Jun 02, 2010
Jkt 220001
PO 00000
Frm 00043
Fmt 4703
Sfmt 4725
E:\FR\FM\03JNN1.SGM
03JNN1
EN03JN10.011</GPH>
sroberts on DSKD5P82C1PROD with NOTICES
31454
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
PO 00000
Frm 00044
Fmt 4703
Sfmt 4725
E:\FR\FM\03JNN1.SGM
03JNN1
31455
EN03JN10.012</GPH>
sroberts on DSKD5P82C1PROD with NOTICES
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
VerDate Mar<15>2010
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
18:55 Jun 02, 2010
Jkt 220001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4725
E:\FR\FM\03JNN1.SGM
03JNN1
EN03JN10.013</GPH>
sroberts on DSKD5P82C1PROD with NOTICES
31456
[FR Doc. 2010–13292 Filed 6–2–10; 8:45 am]
BILLING CODE 4160–01–C
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
sroberts on DSKD5P82C1PROD with NOTICES
Administration for Children and
Families
Office of Child Support Enforcement;
Privacy Act of 1974; Computer
Matching Agreement
AGENCY: Office of Child Support
Enforcement (OCSE), ACF, HHS.
ACTION: Notice of a Computer Matching
Program.
VerDate Mar<15>2010
18:21 Jun 02, 2010
Jkt 220001
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
31457
SUMMARY: In accordance with the
Privacy Act of 1974 (5 U.S.C. 522a), as
amended, OCSE is publishing notice of
a computer matching program between
OCSE and State agencies administering
unemployment compensation (UC)
programs.
DATES: The Department of Health and
Human Services (HHS) invites
interested parties to review, submit
written data, comments, or arguments to
the agency about the matching program
until July 6, 2010. As required by the
Privacy Act (5 U.S.C. 552a(r)), HHS on
E:\FR\FM\03JNN1.SGM
03JNN1
EN03JN10.014</GPH>
Federal Register / Vol. 75, No. 106 / Thursday, June 3, 2010 / Notices
]]>Agencies
[Federal Register Volume 75, Number 106 (Thursday, June 3, 2010)]
[Notices]
[Pages 31450-31457]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-13292]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0004]
[FDA 225-09-0014]
Memorandum of Understanding by and Between the United States Food
and Drug Administration and the International Anesthesia Research
Society for the Safety of Key Inhaled and Intravenous Drugs in
Pediatrics Public-Private Partnership
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is providing notice of
a memorandum of understanding (MOU) between FDA and the International
Anesthesia Research Society (IARS). The purpose of this MOU is to
establish a framework for collaboration between FDA and IARS and to
support their shared interest of promoting the safe use of anesthetics
and sedatives in children.
DATES: The agreement became effective March 21, 2010.
FOR FURTHER INFORMATION CONTACT: Wendy R. Sanhai, Senior Scientific
Advisor, Office of the Commissioner, Food and Drug Administration,
10903 New Hampshire Ave., Bldg. 32, rm. 4128, Silver Spring, MD 20993,
301-796-8518.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 20.108(c), which
states that all written agreements and MOUs between FDA and others
shall be published in the Federal Register, the agency is publishing
notice of this MOU.
Dated: May 26, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
BILLING CODE 4160-01-S
[[Page 31451]]
[GRAPHIC] [TIFF OMITTED] TN03JN10.008
[[Page 31452]]
[GRAPHIC] [TIFF OMITTED] TN03JN10.009
[[Page 31453]]
[GRAPHIC] [TIFF OMITTED] TN03JN10.010
[[Page 31454]]
[GRAPHIC] [TIFF OMITTED] TN03JN10.011
[[Page 31455]]
[GRAPHIC] [TIFF OMITTED] TN03JN10.012
[[Page 31456]]
[GRAPHIC] [TIFF OMITTED] TN03JN10.013
[[Page 31457]]
[GRAPHIC] [TIFF OMITTED] TN03JN10.014
[FR Doc. 2010-13292 Filed 6-2-10; 8:45 am]
BILLING CODE 4160-01-C
